SynthesisOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2026
Anabolic-steroid therapy after geriatric proximal femur fracture: a level I evidence systematic review and meta-analysis of bone density, functional recovery, and safety.
Synthesis in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Older adults often face rapid loss of bone and muscle after a hip fracture, which can hinder recovery and independence. Anabolic steroid therapy increased bone mineral density and enhanced functional performance without notable side effects, showing potential as an adjunct to rehabilitation to support musculoskeletal recovery in postoperative elderly patients.
introductionProximal femur ("hip") fractures are associated with high complication rates and challenging rehabilitation courses in the geriatric population. These patients can develop rapid sarcopenia and bone loss. Anabolic agents such as androgenic anabolic steroids (AAS) might counteract this catabolic state, but their efficacy remains uncertain. The purpose of this systematic review and meta-analysis was to evaluate whether postoperative AAS improves the outcomes in geriatric hip fractures.
methodsA systematic search of MEDLINE, Embase, CENTRAL, Web of Science, Google Scholar, ClinicalTrials.gov, and Wiley (inception to June 1, 2025) identified randomized controlled trials (RCTs) comparing an AAS with placebo/standard care after hip fracture. After record screening and data extraction, the data from studies evaluating AAS were analyzed using fixed-effect modeling. In addition, studies were assessed descriptively. The certainty of evidence was graded using the GRADE system.
resultsNine RCTs (466 total participants; 214 received anabolic agents) met the inclusion criteria. AAS therapy significantly increased hip bone mineral density (BMD) z-score (d = 1.29, 95% CI 1.04-1.55; moderate certainty). The Harris Hip Score (HHS) (d = 2.85, 95% CI 2.52-3.17) and Katz Activities of Daily Living (KADL) index (d = 0.95, 95% CI 0.71-1.19) also improved with anabolic therapy. HHS and KADL index findings had very low certainty due to a high risk of bias and imprecision. No significant gain was observed in operative-leg strength versus the contralateral leg. Thirteen mild, transient adverse events (liver-enzyme elevation, sweating, hirsutism) occurred among AAS patients (13/214, 6.1%). No serious androgen-related complications were reported.
conclusionLow-dose AAS after hip fracture surgery increased BMD and improved patient-reported function without significant safety concerns. Still, evidence of functional benefits is limited by small, often unblinded trials. Larger, multicenter RCTs using standardized treatment protocols and functional endpoints will help better determine the benefits of AAS after proximal femur fractures. LEVEL OF EVIDENCE: Level I, Systematic Review and Meta-analysis.
Indexed as
Identifiers
41249634What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.